Your browser doesn't support javascript.
loading
[Study of vascular risk in Navarre: objectives and design. Prevalence of metabolic syndrome and of vascular risk factors]. / Estudio de riesgo vascular en Navarra: objetivos y diseño. Prevalencia del síndrome metabólico y de los factores mayores de riesgo vascular.
Viñes, J J; Díez, J; Guembe, M J; González, P; Amézqueta, C; Barba, J; Sobejano, I; Martínez-Vila, E; Grijalba, A M; Serrano, M; Moreno, C; Los-Arcos, E; Guerrero, D.
Afiliação
  • Viñes JJ; Servicio de Docencia e Investigación, Departamento de Salud, Gobierno de Navarra, Pamplona. riesgo.vascular@cfnavarra.es
An Sist Sanit Navar ; 30(1): 113-24, 2007.
Article em Es | MEDLINE | ID: mdl-17491613
ABSTRACT

BACKGROUND:

To determine in a representative sample of the population the prevalence of risk factors and metabolic syndrome; their association with sub-clinical atherosclerotic lesions and their impact on cardiocerebrovascular disease 10 years after. MATERIAL AND

METHODS:

(Phase 1) Cross sectional survey of a random sample stratified by age and sex of the population of Navarre aged between 35 and 84. Antecedents, risk factors, physical and analytical exploration. (Phase II) Ten year follow-up cohort study, in 500 exposed to MS and 500 not exposed persons, aged between 45 and 74 years; with an 82.25% power to detect a risk ratio of 2; with analytical and image markers of sub-clinical atherosclerosis. (Phase III) Follow up of vascular events at ten years.

RESULTS:

The subjects recruited were 6,553; excluded or not found 871; the final sample was 5,682 (2,644 men and 3,038 women); 4,168 (73,4%) took part in the study. The prevalence of MS was 22.1% (95%CI 20.5 - 23.7) for men and 17,2% (95%CI 15.8 - 18.5) for women. The main cardiovascular RF were high compared to other geographical areas except for HDL cholesterol. The rate was 8.5% (95%CI 7.4 - 9.6) for men and 1.7% (95%CI 1.3 - 2.2)

CONCLUSIONS:

There are important differences in risk between sex, being worst for men. The high figures for HDL cholesterol and the low prevalence of MS might mean a lower risk of vascular events in Navarra.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Doenças Vasculares / Medição de Risco / Síndrome Metabólica Tipo de estudo: Etiology_studies / Observational_studies / Prevalence_studies / Risk_factors_studies / Screening_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: Es Ano de publicação: 2007 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Doenças Vasculares / Medição de Risco / Síndrome Metabólica Tipo de estudo: Etiology_studies / Observational_studies / Prevalence_studies / Risk_factors_studies / Screening_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: Es Ano de publicação: 2007 Tipo de documento: Article